AnalystBook Research · Company Intelligence

MESABI TRUST

MSBNYSE

Built from MESABI TRUST's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

MESABI TRUST: Revenue grew 331.3% to $98.6M from $22.86M. Net income grew 391.3% to $93.27M from $18.98M. Operating cash flow grew 543.1% to $93.94M from $14.61M. Net margin expanded 1157 bps to 94.60%. MESABI TRUST's annual comparison also shows the manipulation screen is flagged and should be investigated as a warning rather than treated as proof.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue grew 331.3% to $98.6M from $22.86MOK
  • ProfitabilityNet income grew 391.3% to $93.27M from $18.98MOK
  • Cash flowOperating cash flow grew 543.1% to $93.94M from $14.61MOK
  • MarginsNet margin expanded 1157 bps to 94.60%OK
  • AccountingFlagged statistical warning; not proofWatch
  • Insiders0 purchases and 0 salesNote

Business

Market for Registrant's Common Equity, Related Unitholder Matters and Issuer Purchases of Equity Securities 5 ITEM 6.

Where the revenue comes from

Fiscal 2026, as MESABI TRUST reports it. History and quarterly detail are in the app.

  • Royalties From Leases$15.8M
  • Royalties From Lease Fees$750K

Latest filings

  • 8-K · Company announcement2026-07-31
  • 8-K · Company announcement2026-07-14
  • 10-Q · Quarterly report2026-06-12
  • 8-K · Company announcement2026-05-04
  • 10-K · Annual report2026-04-22
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about MESABI TRUST, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.